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Abstract (=150 words) 
 
There is an acute clinical need for small-diameter vascular grafts as a treatment option for 
cardiovascular disease. Here, we used an intelligent design system to recreate the natural 
structure and hemodynamics of small arteries. Nano-fibrous tubular scaffolds were 
fabricated from blends of polyvinyl alcohol and gelatin with inner helices to allow a near 
physiological spiral flow profile, using the electrospinning technique. Human coronary artery 
endothelial cells (ECs) were seeded on the inner surface and their viability, distribution, 
gene expression of mechanosensitive and adhesion molecules compared to that in 
conventional scaffolds, under static and flow conditions. We show significant improvement 
in cell distribution in helical vs conventional scaffolds (94% ± 9% vs 82% ± 7.2%; p<0.05) with 
improved responsiveness to shear stress and better ability to withhold physiological 
pressures. Our helical vascular scaffold provides an improved niche for EC growth and may 
be attractive as a potential small diameter vascular graft.  
 
 
Keywords 
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Background 
Cardiovascular disease (CVD) is a leading cause of death worldwide 1. In particular, coronary 
artery disease (CAD) affecting small and medium-sized blood vessels accounts for 53% of the 
total mortality 1, 2. Despite significant improvement in treatment options, the therapeutic 
gold standard remains the coronary artery bypass graft (CABG) 3. The most preferable 
option for these transplants are autologous grafts but many patients lack suitable vessels for 
grafting due to pre-existing  vascular disease, amputation, or previous harvest 3, 4, 5. Even in 
the case of synthetic grafts, which have been used as an alternative for large diameter 
vascular grafts with considerable success rates, they have not proved to be very effective for 
smaller diameter vessels 5.  
Two major causes for early small diameter graft failure are hemodynamic mismatch 
between the host artery and the graft; and the lack of graft endothelisation 6, 7. A healthy, 
confluent inner endothelium is essential in maintaining vascular homeostasis through the 
release of mediators that modulate vessel diameter, including nitric oxide 8. An intact 
endothelial layer also acts as a continuous, structural and thrombo-resistant barrier 
between circulating blood and the wall of the vascular graft 9. Therefore, enabling the 
seeding and growth of a physiologically healthy endothelium on the inner wall of the 
implanted vascular graft is a pre requisite for its survival. The hemodynamic environment 
within the vascular graft also plays a major role for its survival after implantation 10. In small 
diameter vessels, hemodynamics is mainly represented in terms of impedance to flow, wall 
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shear stress (WSS), velocity profile of blood, and flow separation. For larger diameter 
vessels, the effect of impedance is largely suppressed by higher blood flow rate, which help 
to absorb greater energy of the disturbance compared to smaller diameter counterparts. 
Such disturbed flow behaviour of blood is implicated in the formation of atherosclerotic 
plaques and phenomena such as thrombogenesis, artherogenesis, endothelial cell (EC) 
damage, intimal thickening and hyperplasia 11. 
The geometry of arteries influences their blood flow motion and hence their biology and 
susceptibility to disease. It is recognized that the geometry of natural blood vessels is far 
more complicated than that of model vessels, which influences the local flow pattern and its 
velocity distribution 12, 13. Native arterial geometry is three-dimensional, causing blood to 
flow in a spiral/ helical manner 14, 15. In a survey of a 3 dimensional arterial flow pattern in a 
group of 42 volunteers, eleven arterial sites were examined, including the common carotid 
artery and femoral arteries, spiral laminar flow was shown as the predominant flow pattern 
16. Spiral laminar flow has been shown to provide relatively uniform WSS and inhibit flow 
stagnation favouring EC growth and release of artheroprotective mediators that improve 
patency 17, 18, 19. Therefore, improvement in blood flow haemodynamics in terms of 
spiral/helical blood flow is essential to enhance the success rate of small diameter vascular 
grafts in the long term.  
Exposure of ECs to unidirectional laminar shear stress (imparted by the frictional drag of 
flowing blood within the arteries) is associated with upregulation of mechanosensor 
molecules. These trigger the signalling of mechanotransduction pathways and induction of a 
number of mechanosensitive transcription factors, such as Piezo 1 and Nuclear factor-like 2 
(Nrf-2) which is a master antioxidant regulator and also associated with atheroprotective 
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responses 19. These signal transduction mechanisms stimulate the release of vasoactive 
molecules, such as nitric oxide and prostacyclin that modulate arterial diameter 9. In 
contrast, exposure of coronary arteries to asynchronous disturbed flow has been 
demonstrated to elicit a pathologic gene expression pattern 20, 21. For long-term graft 
success it is thus necessary that the hemodynamics generated maintain the expression of 
mechanosensitive genes and support an atheroprotective phenotype. 
A further cause for small diameter graft failure is the surface mismatch, which hinders graft 
endothelisation after implantation 22,23. Blood vessels are well-organized hierarchical fibrous 
structures with an extracellular matrix (ECM) that realigns at the nanometre scale.  
Electrospinning technology enables the fabrication of nano-structured vascular scaffolds 
with a complex porous architecture. Using appropriate polymers of synthetic or natural 
origin, these constructs can replicate the biomechanical and structural properties of native 
vessel walls providing support for cell attachment, proliferation and differentiation 24, 25, 26. 
Moreover, the mechanical and biological properties of fibers can easily be tuned by varying 
material composition, not easily achievable using other nano-scaffold fabrication methods 
25. Hence, in addition to matching the natural vessel’s nano and macro structure, including 
wall thickness, this fabrication method should also replicate other important biomechanical 
indices, such as burst pressure, elasticity and compliance, which are key to graft function 25, 
27.  Synthetic polymer materials are often employed in vascular graft designs mainly due to 
flexibility in tailoring their mechanical properties. Of particular interest, is poly [Vinyl 
Alcohol] (PVA) since it is water soluble, biocompatible, biodegradable and has excellent 
chemical and thermal stability. 28 Furthermore, hydrogels made from PVA exhibit tissue-like 
elasticity and mechanical strength, with microscopic properties similar to those of native 
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arterial tissue .29, 30  PVA can be co-spun with natural molecules, such as collagen, which 
constitutes the major architecture of the native ECM, in order to provide cell attachment 
sites for improved cell seeding. As gelatin is prepared by partial hydrolysis of collagen it has 
high biocompatibility and bioactivity. Furthermore, gelatin can react with hydroxyl groups 
and positively charged polymers such as PVA to create a 3 dimensional porous architecture, 
providing a good substrate for the adhesion and proliferation of vascular endothelial cells.31, 
32  Hence, PVA-gelatin blends show promise for vascular graft applications. 32  
The objective of the present study is to fabricate a small diameter vascular scaffold that 
closely mimics the ultrastructure and haemodynamics of native vessels, using computational 
fluid dynamic (CFD) simulation and the electrospinning technique, in order to recreate the 
natural environment for supporting EC survival and growth, hence the likelihood of long-
term graft patency.  
 
Methods:  
Materials: Poly (vinyl alcohol) (PVA, 99% hydrolyzed, number average MW 89,000–98,000 
g/mol) were obtained from Aldrich Chemical Co (UK). Gelatin (Ge) Type A (Approx. 300 
Bloom) from porcine skin were obtained in powder form (Aldrich Chemical Co., UK). 
Methanol (99% Pure, HPLC grade), glacial acetic acid (99% pure) were obtained from Fisher 
scientific; Human Coronary Artery Endothelial Cells (HCAEC), passage 4 (PromoCell, 
Germany). Physiological Salt Solution (PSS) was prepared as previously described. 33 
Scaffold design and fabrication: Using computational fluid dynamic (CFD) simulation, a new 
scaffold structure with a small diameter of 4mm was designed with inner helices to enable a 
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‘spiral flow’ effect with better shear stress profile. The new scaffold model is a rigid tube 
with specific number of (2, 3 or 4) helices on the inner surface with different number of 
revolutions (1, 2 or 3) along the entire length (taken as 100mm).  A starting angle of 650 for 
helix creation was used to eliminate any mismatch during anastomosis and obtain the best 
possible WSS distribution. To simplify the CFD analysis, blood flow was considered to be 
Laminar, and the unsteady three-dimensional Navier-Stokes equations were used as the 
governing rules.  Blood was considered as  homogeneous, incompressible, and Newtonian, 
with a constant viscosity of 3.5×10−3 kg·m−1·s−1 and density of 1050 kg·m−3. Reynolds 
number (Re) was kept at 300, as used in previous studies.34, 35 The boundary conditions for 
the helical scaffold were then set as follow: (1) At the inlet, uniform velocity profile with a 
mean velocity of 0.372 m/s; (2) At the outlet,  pressure, p was set at 1.33×104 Pa (100 
mmHg); (3) The vessel wall was assumed to be rigid and non-slippery. Simulation studies 
were then carried out and parameters such as shear stress and vorticity, in the centre and 
peripheral areas, were calculated and compared with the conventional scaffold as well as 
within the different helical scaffolds. Optimum designs were then selected for further 
consideration.  
Small diameter vascular scaffolds were produced by electrospinning using a blend of PVA 
and gelatine (PVA:Ge 8:2).  The scaffold design which displayed the best hemodynamic 
properties without affecting or obstructing the blood flow, was selected for further analysis. 
As part of this effort, a unique design with 2 helices and 1 pitch of rotation throughout 
scaffold length with starting angle of  65
0
 was selected. This design creates swirling flow of 
the blood which was shown to perform best. To produce the conventional scaffold, a plain 
stainless-steel mandrel was used as a collector.  It was imperative to optimise the rotating 
speed of the mandrel as being one of the process parameters that may affect the quality of the 
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fibrous structure. Therefore, the nanofibers were collected at rotating speeds of 1000 rpm 
when evaluated in terms of their morphological appearances and changes in alignments. The 
same size tubular mandrel with two helical grooves with one revolution and 1 mm depth was 
used as a collecting device to manufacture the helical scaffolds. Further information on 
manufacturing procedure for the helical scaffold design is detailed in a filed patent 
application No: GB1616064.  
Electrospinning parameters used were as follows: Solution:- PVA M.Wt. 89,000–98,000 
gm/mol;  Gelatine Type A (300 Bloom); PVA solution 12.5% w/v in deionised water;  
Gelatine 12.5% w/v in Acetic acid:water ratio, 2:8; PVA: Ge mixing ratio, 8:2.  Process 
parameters were: Voltage:  16 kV; Tip to collector distance: 15 cm; Flow rate: 1 ml/hr; 
Needle gauge: 18 G; Mandrel Diameter:  4 mm; Rotating speed: 1000 rpm. All the processes 
were carried out at room temperature and normal atmospheric humidity. 
PVA and gelatine were dissolved in their corresponding solvents and the solutions were 
mixed together in a specific ratio of 8:2. The spinneret was traversing along the axis of the 
mandrel throughout its length to ensure uniform distribution of the fibre along the mandrel. 
Finished scaffolds (4 cm long) were allowed to dry overnight to ensure evaporation of 
residual solvents. In order to overcome instability in water, the scaffolds were cross-linked 
by physical (rather than chemical) means using methanol treatment. Methanol links the 
polymer network by intermolecular forces, including hydrogen bonding, and supports cell 
seeding and growth.28   Fourier Transform Infra-Red spectroscopy (FTIR) analysis, differential 
scanning calorimetry (DSC), as well as dissolvability tests were carried out to identify any 
changes to the fibres after cross-linking (See supplementary information for details). 
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Scaffolds were subsequently stored in a sterile container for further mechanical and 
structural evaluation. 
  
Scaffold characterisation:  The morphological characteristics of the scaffolds were analysed 
by scanning electron microscopy (SEM; Hitachi, S3400N, Berkshire, UK).  Scaffold and 
nanofibre samples were placed on aluminium stubs and sputter coated with gold/palladium 
for 45 sec at 18 mA using a sputter coater (Polaron Sc7620, Quorum technologies Ltd, UK), 
then scanned at an accelerating voltage of 7 kV. SEM images were captured to determine 
the inner and outer morphologies of the scaffolds and to evaluate the dimensions of the 
helices on the inner surface. Fibre diameter was measured by taking the average of 60 
measurements chosen randomly from across the image, using Image J software (Image J, 
National Institutes of Health, Bethesda, USA). Scaffold thickness measurements were made 
using a high precision calliper. Five samples were measured per scaffold. The tensile 
properties of the electrospun fibrous membranes were determined using a universal tensile 
testing machine (INSTRON 2530). A test window frame was used to hold the membrane and 
measure its thickness using a micrometre screw gauge. The test specimen was then 
mounted on the tensile tester (specimen dimension: 50 x 12 mm; gauge length 24 mm; 
strain rate 5 mm/min; load cell 100 N). Only test samples that failed at least 2 mm from the 
edge of the tab were included in the test results for the calculation of the stress strain 
behaviour. For tensile testing of the tubular scaffolds, a 10 cm length was soaked in PSS 
overnight at room temperature, then mounting on a uniaxial load test machine equipped 
with a maximum 2kN load cell (cross head speed 0.5 mm/s). Tensile stress-strain plots were 
generated and the elastic modulus calculated using least-squares fit in the linear range of 
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the stress-strain plot. Ultimate tensile strength was measured as the highest stress value 
attained during the test. For burst pressure testing, an angioplasty balloon of matched 
diameter was inserted into the scaffold and hydrostatic pressure recorded until bursting 
occurred. The burst pressure was recorded as the maximum pressure prior to construct 
failure (n=5). In all cases, rupture occurred away from the cannulation site.  To measure 
suture retention strength, the force necessary to pull a suture through the wall of 
electrospun scaffolds was measured. Three sutures were inserted 2 mm from the end of the 
scaffold at 90° angles and mounted on a tensile test instrument. One end of the scaffold was 
directly placed under the grips, while the other end was secured and pulled at a rate of 50 
mm/min until the suture pulled through the vessel wall. Compliance testing: Scaffolds were 
mounted on cannulas using sutures and submerged in PSS (37°C). After equilibration, 
scaffolds were inflated from 0 to 200 mmHg in 10 mmHg increments using a syringe pump, 
then deflated again in 10 mmHg decrements. Outer diameters were recorded at each 
pressure level. Percentage diameter change relative to the diameter at 0 mmHg was 
calculated as ΔD=(Dp-D0)/D0 x 100; where ΔD is the percentage diameter change, Dp is the 
diameter at a specified pressure, and D0 is the reference diameter at 0 mmHg.  
Cell culture:  Human Coronary Artery Endothelial Cells (HCAEC) were grown as a monolayer 
at 37°C under 5% CO2 atmosphere in EC growth medium MV (PromoCell) supplemented 
with 5% FCS (Invitrogen), 0.004 µl/ml endothelial growth supplement, 10 ng/ml epidermal 
growth factor and 90 μg/mL heparin. Cells were washed x3 in PBS and incubated with 0.1% 
trypsin for 3 min to detach them from the flask surface. Cells were then centrifuged at 220g 
for 3 min and resuspended in medium. Scaffolds were sterilized by immersion in 70%, 50%, 
25% ethanol, and sterilized PBS (cell culture grade) for 30 min, washed twice, then 
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conditioned in growth medium overnight. Cells were seeded in the center of the scaffolds 
(100,000 cells) and both ends sealed with sterile thread and placed in an incubator for 2 hrs 
initially at 370C, 5% CO2under constant rotation, on a flow circuit in culture medium. At 
specified time points (day 1, 3, and 5), seeded scaffolds were opened using a sterile razor 
along the length of the scaffold and analysed. 
Cell Morphology and distribution:  The morphology and proliferation of ECs seeded on the 
inner lumen of the scaffolds were examined by Scanning Electron Microscopy (SEM) and 
fluorescence microscopy. Seeded scaffolds were washed in PBS x3, fixed in 2.5% 
glutaraldehyde and dehydrated with a series of graded ethanol solutions. The dried samples 
were coated with gold using a sputter coater and observed by SEM under an accelerating 
voltage of 3 kV. Cells were analyzed using live/dead cell viability assay (Live/dead Cell 
Viability Assay kit, Invitrogen). Samples were washed for 5 min in PBS and incubated in a 
solution of 2 μM Calcein AM (live) and 4 μM Ethidium homodimer-1 (dead) solution in PBS 
for 30 min. Samples were imaged with an Inverted Fluorescence microscope using a 
conventional fluorescein long pass filter. 
Distribution of ECs along the length of the scaffolds over 1-5 days (plus an extended time 
period of 7 days) was evaluated by monitoring cell metabolic activity at different locations 
within the scaffolds, using Presto Blue (PB) (n = 5). Three samples (10x10 mm2) were taken 
from 3 different locations along the scaffold (one from the center and two 1.5 cm away 
from the site of seeding in both directions toward scaffold opening) 33. PB reagent (1mL of 
10%) was added to each well of a 24-well culture plate containing cell seeded scaffold, and 
incubated at 37 °C for 2 hrs. Changes in cell viability were detected using fluorescence read 
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at excitation 570 nm emission wavelength. Percentage reduction of PB was calculated 
according to supplier’s information36. 
Measuring cell proliferation: The degree of cell proliferation was measured indirectly 
through cell fluorescence methods as previously described 37, 38  in the conventional and 
helical scaffolds, at days 1, 3, and 5. Total corrected cellular fluorescence was performed 
using Image J software, using the following fomulas: total corrected cellular fluorescence 
(TCCF) = integrated density – (area of selected cell × mean fluorescence of background 
readings). Measurements of at least 5 cells were taken and averaged, for each scaffold. 
Pressure Myography studies: Scaffolds were mounted on an inflow and outflow stainless 
steel cannulae within a pressure myography chamber and secured with ligatures. The 
cannula at the inflow site was connected to a pressure transducer and pressure servo 
control system (Living systems instrumentation, USA), and infused with PSS at 37oC. The 
chamber was placed under an inverted microscope, connected to a video dimension 
analyzer, camera and a monitor. The diameter of the scaffold was measured continuously 
using Lab Chart (AD instruments, UK). Both helical and conventional scaffolds were mounted 
before (day 0) and after complete endothelization (at the extended time of 7 days). 
Intraluminal pressure was introduced via the pressure servo control system, at 60mmHg and 
100 mmHg, over 1 hr. In another set of experiments, the scaffold’s ability to withhold 
maximum pressure was assessed by increasing the pressure at 20 mmHg increments, up to 
the maximum retained in mmHg. 
Gene expression analysis: HCAECs were seeded on the inner surface of the scaffold and 
allowed to proliferate over 4 days under static conditions to cover the entire surface of the 
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scaffold. Cell-seeded scaffolds (helical and conventional) were mounted on 4 mm stainless 
steel cannulas within a flow chamber and exposed to flow (Watson Marlow pump, UK) at 27 
µl/min  for 0, 2, 6 and 24 hrs. Cells were then detached from the scaffold using TripleE and 
treated with RNA lysis buffer, snap frozen in dry ice, then stored at -80°C for subsequent 
gene expression analysis, using the quantitative real-time polymerase chain reaction (qRT-
PCR). Shear stress imparted on the endothelial cells was calculated using the following 
equation: 
               τ = 4 ή Q / π r3 
where τ is shear stress (dyn/cm2), ή is viscosity (0.007 dyn.s/cm2), Q is flow (in ml/s) and r is 
radius (in cm). 33  
To analyse gene expression, RNA was isolated according to manufacturer protocol using 
GenElute Mammalian Total RNA Miniprep Kit (Sigma Aldrich, UK). The purity and 
concentration of RNA was measured using Nanodrop. The RNA was synthesized to cDNA 
using Random primer (250ng, Promega), dNTPs (0.5mM, Promega), 25U Superscript II 
(Invitrogen), RNase Out (Invitrogen), 0.1M DTT (Invitrogen) and 5x 1st strand buffer 
(Invitrogen). The level of gene expression was quantitatively determined using SensiMix 
SYBR® Low-ROX kit (Bioline). All PCR reactions were performed in biological and technical 
triplicates using Quant Studio 12K Flex instrument (Applied Biosystem). Each of the genes 
were normalized to housekeeping gene GAPDH and the relative gene expression were 
analysed using 2−ΔΔCT method.  Raw CT values greater than 35 were removed from analysis. 
Expression values were calculated using the formula:  
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Ex = 2(CThk - CTx)   
Where CThk  is the CT value of the housekeeping genes. P-values were calculated using 
Welch’s t-test. All primers were designed using NCBI primer blast tool 39  and experimentally 
validated to have >98% efficiency with single dissociation peak. All the primer sequences are 
listed in Table 1.  
Statistical analysis: All experiments were performed in quadruplicate at least three 
independent times, and the results presented are representative data sets. Cell counts are 
expressed as means ±SD. Statistical analysis was performed using Student’s t-test, where 
p<0.05 was considered significant. 
 
Results 
Hemodynamic analysis: A comparison of haemodynamics performance between the 
various proposed designs was initially carried out. A considerable difference in WSS profile 
between the conventional and helical scaffolds was evident, when blood flow was simulated 
(Figure 1A). The observed WSS was much higher in scaffolds with 2 or 3 helices as compared 
to those with 1 helix feature or in the conventional scaffold. The insertion of more than 3 
helices was excluded as this would result in higher resistance to flow, lower velocity of fluid 
and pressure drop which can lead to premature failure of the grafts. 
Fabrication and characterization of nano-fibrous scaffolds: We developed a unique post-
production technique to fabricate scaffolds with inner helices throughout their length 
a c 
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[Figure 1B].  The mechanical properties of the helical scaffold were comparable to that of 
human vessels, achieving similar ranges of wall thickness, compliance and elasticity to 
arteries 40  [Table 2]. Fibre diameter ranged from 320 nm to 520 nm in the scaffolds [Figure 
1C].   The nanofibres observed on the luminal surface of the helical scaffold were randomly 
oriented and fine-structured resembling that of the ECM [Figure 1D]. 
 
Cell viability, survival and distribution within the vascular scaffold: 
Cell viability: For both conventional and helical scaffolds, ECs adhered and spread very well 
on the surface of the scaffold over the 5 day incubation period [Figure 2A]. The Live–dead 
cell viability analysis on the luminal surface of the scaffolds revealed primarily live cells, with 
little evidence of dead cells. The green stained (live cells) and red stained (dead cells) ECs 
attached to the electrospun fibres of both scaffolds [Figure 2B]. Cells on the helical scaffold 
had a more elongated morphology and were more evenly distributed than cells grown on 
the conventional scaffold. ECs proliferated along the entire scaffold surface and by day 5, 
percentage live cells were 94% ± 9% and 82% ± 7.2% on the helical and conventional 
scaffolds, respectively.  On the day of seeding, cells were present only in the center portion 
of the scaffold. As incubation time proceeded, a clear difference was observed in viable cell 
number and migration towards the peripheral area, between the helical and conventional 
scaffolds (Figure 2C). After 7 days, number of viable cells in the conventional grafts were 
4.64 x 105 ± 28,000 cells/cm2 (middle of the graft) and 3.1x105 ± 15,000 cells/cm2 (near 
scaffold end). For helical scaffolds, there were 5.2x105 ± 42,000 cells/cm2 (middle of the 
scaffold) and 5.2x105 ± 36,000 cells/cm2 (near scaffold end) [p<0.05]. Hence, there was a 
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significant difference in cell distribution between helical and conventional scaffolds along its 
length. Also, migration was more uniform along the length of the helical than the 
conventional scaffold. These results are in line with the live dead cell viability analysis. In 
both cases, the growth rate for the first day after seeding was comparatively lower than the 
remaining incubation periods.  
Cell proliferation: As a surrogate measure of cell proliferation, the degree of cell 
fluorescence was measured for cells in the conventional and helical scaffolds over the 
incubation periods, at days 1, 3, and 5. Total corrected cellular fluorescence was reduced 
over day 3 and 5 compared to day 1, for cells grown within the conventional scaffolds. In 
comparison, fluorescence levels were increased by over 10 fold  after days 3 and 5 
compared to day 1, for cells grown within the helical scaffolds (Figure 2D). 
Functional pressure analysis: As a measure of improved surface coverage by ECs, the ability 
of endothelialized grafts to with-hold intraluminal pressure was evaluated by mounting the 
scaffolds within the pressure myography system. In the absence of any cells, scaffolds were 
not able to maintain intravascular pressure beyond 30 mmHg, over any length of time. After 
7 days of culture both helical and conventional scaffolds were mounted onto the pressure 
chamber. Intravascular pressure was increased by 10 mmHg increments to 200 mmHg over 
a 1-hour time period. The maximum pressure achieved was 60 and 200 mmHg for 
conventional and helical scaffolds, respectively before starting to lose pressure (Figure 3A). 
In the next set of experiments, intravascular pressure was elevated to 60 mmHg and 
pressure retention monitored for both scaffolds. Within 45 min, the conventional scaffold 
started losing pressure, while the helical scaffold was able to sustain elevated pressure 
beyond 1 hr (Figure 3B). 
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Cell adhesion and attachment during flow: Cell adhesion was implicated by examining gene 
expression for adhesion molecules, in both types of scaffolds, at the early time points, under 
static conditions, initially. Significant elevation in CDH5 gene expression was evident at the 
early time points (2 and 6 hrs) in ECs from helical vs conventional scaffolds (p<0.05 and 
p<0.01 at 2 and 6 hr, respectively)- Figure 4A. Significant elevations were also evident after 
6 hr for Beta 1 integrin (p<0.05), alpha 5 integrins (p<0.01), and VCAM-1 (p<0.01) in the 
helical scaffolds (versus conventional).  These findings suggest that ECs grown within helical 
scaffolds show improved adhesion, over those grown within conventional scaffolds.  
In order to recreate the physiological responses expressed by ECs, both conventional and 
helical scaffolds were seeded by ECs and maintained under flow conditions over 24 hrs (at 
0.5-1 dyn/cm2).  The influence of flow on gene expression was assessed at both the early (2, 
6 hrs) and the longer time point of 24 hrs. At the early time points, elevation in adhesion 
molecule expression was evident in ECs from helical scaffolds for CDH5 (significant at 2 hr, 
p<0.01); for beta 1 integrin; alpha 5 integrins (significant at 2 and 6 hr, p<0.05 and p<0.01, 
respectively); and VCAM-1 (p<0.05 and p=0.05, at 2 and 6 hr respectively). For all adhesion 
molecules examined, there was no significant difference in expression between helical and 
conventional scaffolds, after 24 hrs. These results demonstrate that while improved 
adhesion was evident at the early time points within helical scaffolds, response to flow after 
24 hrs was similar for ECs seeded in both conventional and helical scaffolds.  
Expression of mechanosensitive genes by ECs within scaffolds: In the absence of flow, no 
overall mRNA expression of Nrf2 or HO.1 was evident in the conventional grafts at any of 
the time points. In the helical scaffolds, Nrf2 mRNA gene expression was significantly 
downregulated at 2 and 6 hr (p<0.05), but upregulated for HO.1 mRNA levels (significantly 
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at 6 hr, p<0.01). When flow was introduced, there was no overall increase in Nrf2 mRNA 
gene expression at any of the time points (2, 6, 24 hr), however, levels were clearly elevated 
for HO.1 mRNA levels (significant at 2hr and 24 hrs, p<0.01), in helical scaffolds Exposure to 
flow over 24 hrs also led to a significant increase in KLF2 gene expression (p<0.01) [Figure 4 
B]. Additionally, for Piezo 1, an important flow sensitive mediator of mechanotransduction, 
there was no upregulation in mRNA levels in the conventional scaffold under either the 
static or flow conditions.  When flow was introduced, there was a significant upregulation in 
levels after 2 (p<0.001), 6 (p<0.05), and 24 hrs (p<0.001) in the helical scaffolds. ECs grown 
under flow conditions were thus flow responsive, especially when grown within helical 
scaffolds.   
 
Discussion 
Using CFD simulation and the electrospinning technique, we have designed and fabricated a 
novel small diameter helical vascular scaffold that provides an improved niche for the 
survival of ECs, than conventional scaffolds, with improved responsiveness to shear stress 
and the ability to retain physiological levels of intravascular pressure.   
A new design, which can provide spiral flow throughout the scaffold, was evaluated in the 
present study and parameters optimised to ensure that the generated spiral flow would be 
within the allowable physiological limits, as excessive amounts of WSS or blood particle 
velocity can damage the vessel walls and produce adverse effects.41 CFD experiments 
related to spiral geometries have previously mainly focused on physical twisting of the 
principal geometry. 42, 43  Shorter helical pitch or larger amplitude are known to enhance 
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WSS in 3D geometries and decrease the low and high velocity zone ratios. 29, 30  It has been 
established that normalised axial WSS would potentially improve mass transfer and 
minimum pressure drop on graft with internal helices angles in the region of 400 to 650. 
Although such designs have had beneficial effects, they can increase pressure drop, which 
can lead to excessive flow resistance at fixed flow rates which may create haemodynamic 
failure. 42  Also, the flow profile can cause flow stagnation and inhabitation which makes the 
graft vulnerable to intimal hyperplasia and thrombosis, if implanted. 42  Furthermore, due to 
the twisting effect, change in the physical geometry is relatively sharp, which could lead to 
sudden alteration in shear stress levels and have adverse effects on the cells. Therefore, an 
optimal structural design was required which would provide a gradual change in the spiral 
geometry thus providing better validation with the natural flow profile and uniform WSS 
distribution. Hence, the proposition to insert helices within the inner walls rather than the 
physical twisting of the whole graft was adopted in the present study. Using numerical 
simulation, Kabinejadian and colleagues were able to demonstrate significant effectiveness 
of out-of-plane helicity and spiral ridge features of grafts in inducing swirling flow. This was 
influenced by ridge height and number of ridges where multi-ridge designs result in higher 
WSS magnitudes on the arterial bed, further confirming our findings. 44 Our helical scaffolds 
were fabricated using the electrospinning technology. Using electrospinning in conventional 
form, other researchers have been able to produced 3D nano-fibrous tubular scaffolds with 
a large range of vessel diameters. 24 The morphological and mechanical analysis performed 
on our electrospun scaffolds confirmed the presence of the helical structure within the 
tubular scaffold with mechanical properties comparable to those of native vessels.  
Moreover, as the delivery needle was continuously travelling along the length of the 
mandrel, tubular structures of uniform thickness were produced. 24 
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One of the major reasons attributed to graft failure is the lack of a uniform layer of ECs on 
the graft surface or poor attachment of the cells. ECs cultured within our helical scaffolds 
demonstrated improved viability and proliferation in comparison to those cultured within 
the conventional scaffolds, over the 5-7 day incubation period. Furthermore, there was a 
significant increase in cell distribution over the length of the helical than the conventional 
scaffolds. This was further confirmed by assessing the ability of the cell-seeded scaffolds to 
withhold physiological ranges of intravascular pressure.  Our endothelialized helical 
scaffolds were better able to withhold and sustain physiological pressures within the range 
that vessels of similar diameter are exposed to in vivo. This may relate to improved cell 
attachment, distribution and spreading along the entire surface of the helical scaffold. 
Improved cell viability, proliferation and distribution, is supported by evidence of improved 
cell-cell contact and cell adhesion to the electrospun fibres, as shown by upregulated 
expression of CDH5, Beta 1 integrin, alpha 5 integrins, and VCAM-1, in the helical 
scaffolds.45, 46  
Whilst integrin molecules are associated with mechanotransduction, other 
mechanosensitive genes are also key to the transmission of mechanical stimuli into 
intracellular biochemical signals. These include genes associated with atheroprotective 
responses, such as Nrf2. The latter is a key transcription factor that is highly sensitive to 
laminar shear stress, leading to its increased stability and its translocation to the nucleus 
where it binds to the anti-oxidant response element (ARE) of antioxidant genes, including 
heme oxygenase-1 (HO-1). 19  Gene upregulation was initially examined herein, in ECs grown 
in conventional and helical scaffolds under static conditions. EC seeded scaffolds were 
subsequently exposed to flow over a 24 hr period (at 0.5-1 dyn/cm2), in order to recreate 
the physiological responses in vivo and assess the responsiveness to acute effects of shear 
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stress on EC gene upregulation. Our results demonstrate that while improved adhesion was 
evident at the early time points within helical scaffolds, the response to flow after 24 hrs 
was similar for ECs seeded in both conventional and helical scaffolds. Nonetheless, the 
significant upregulation of the mechanosensitive genes (HO.1; Peizo1; KLF2) after 24hrs 
confirms EC responsiveness to the shear stress imparted by the fluid flow within the helical 
scaffolds. Whist Nrf2 gene expression was unaltered, we show a significant increase in HO.1 
expression after flow, consistent with previous findings. 19, 47 The expression of adhesion 
molecules and mechanosensitive genes has previously been demonstrated within ECs 
exposed to steady laminar flow at a range of flow rates within 7 -24 hrs. 21, 46, 48-50  The 
significant increase in KLF2 gene expression demonstrated in the present study after 
exposure to flow (24 hr, p<0.01), further supports the increase in HO.1 expression since 
KLF2 has been shown to upregulate the expression of antioxidant pathways and also eNOS, 
hence generation of nitric oxide, supporting atheroprotection. 19, 50  
 
In conclusion, we have designed and fabricated a novel small diameter helical vascular 
scaffold that provides an improved niche for the survival of ECs, over a conventional tubular 
scaffold. The novel scaffold environment enables enhanced cell viability and distribution, 
and demonstrates improved responsiveness to shear stress and ability to retain 
physiological levels of intravascular pressure. Hence, in addition to showing potential as a 
graft for preclinical testing, these helical scaffolds can be utilised as a tool to study EC 
behaviour under an environment that mimics more closely the natural structure of real 
vessels.   
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TABLE LEGENDS  
Table 1: List of Primers used for qRT-PCR to assess gene expression patterns by endothelial 
cells.   
Table 2: Comparative mechanical properties of electrospun helical grafts (4 mm internal 
diameter) with that of human vessels.  
 
FIGURE LEGENDS 
Figure 1: Scaffold fabrication and characterisation. (A) Scanning electron micrograph of the 
conventional and helical scaffolds showing the inside structure with inner helices identified 
for the helical scaffold. (B) The wall shear stress profile of the conventional and helical 
scaffolds with a number of helices on the inner surface. A histogram showing fibre diameter 
range (C) and distribution (D) of the fabricated scaffolds. 
 
Figure 2: Endothelial cell culture and distribution within the conventional and helical 
scaffolds. (A) Scanning electron micrographs of Human Coronary Artery Endothelial Cells 
(HCAEC) cultured on the inner side of conventional and helical electrospun scaffolds (3 keV). 
(B) Live–dead cell staining of endothelial cells seeded on conventional and helical scaffolds. 
Assay stains are merged [live cells green, dead cells red (nuclei only)]. Figures are 
representative of the scaffold. Scale bar is 25μm. (C)  Cell viability across the entire scaffold, 
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assessed using the Presto Blue assay. The results are expressed as means (±) SD. *p<0.05. 
(D) Degree of cell fluorescence of the HCAECs after seeding in the conventional and helical 
scaffolds. ** p<0.001. 
 
Figure 3: Pressure retention within the helical and conventional grafts after a 7 day 
incubation period with ECs. A) Maximum intraluminal pressure achieved after step-wise 
elevation in pressure. B) Intraluminal pressure monitoring over a period of 1 hour after 
pressure elevation to 60 mmHg. *p<0.01; n=5. 
 
Figure 4:  Adhesion molecule and mechanosensitive gene expression by endothelial cells 
(ECs) seeded within the conventional and helical scaffolds, over acute times of 2, 6, and 
24hr, in the absence and presence of flow. (A) significant elevation in adhesion molecule 
expression for beta 1 integrin, alpha 5 integrin and VCAM-1 is evident in the helical 
scaffolds, under static and early time points of flow. (B)  Flow induced a significant elevation 
in HO.1 but not Nrf-2 mRNA in the helical scaffolds. Flow also induced a significant elevation 
in KLF2 and Piezo-1 mRNA expression by ECs from the helical scaffolds in comparison to 
those from conventional scaffolds. 
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Table 1: List of Primers used for qRT-PCR. 
GENE SPECIES  SEQUENCE 
VE-Cadherin Human FWD CTTCACCCAGACCAAGTACACA 
  REV GGCTCATGTATCGGAGGTCG 
VCAM-1 Human FWD GTTTGCAGCTTCTCAAGCTTTTA 
  REV TCACCTTCCCATTCAGTGGA 
Integrin α5 Human FWD CCAGATCCTGTCTGCCACTC 
  REV GTAGGAGGCCATCTGTTCCC 
Integrin β1 Human FWD CCGCGCGGAAAAGATGAAT 
  REV ATGTCATCTGGAGGGCAACC 
NRF2 Human FWD GTGCTGTCAAGGGACATGGA 
  REV TTTGGGAATGTGGGCAACCT 
HO-1 Human FWD GACAGCATGCCCCAGGATTT 
  REV ATCACCAGCTTGAAGCCGTC 
KLF2 Human FWD CGGCAAGACCTACACCAAGA 
  REV TGGTAGGGCTTCTCACCTGT 
Piezo1 (FAM38A) Human FWD 
GCTGAAAAGACAGATGGAGCG 
  REV CCTCGGGTCTTCAGGAACAG 
GAPDH Human FWD AGGCTTTGGACGGCCTCTGGAA 
  REV CGAATGACACCGTACTCCTCATAGAAGCT 
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TABLE 2: Comparative mechanical properties of electrospun helical grafts (4 mm internal 
diameter) with that of human vessels (from published literature). 40 
 
 
Sample Wall 
Thickness 
(µm) 
Burst 
Pressure 
(mm Hg) 
% 
Compliance 
 (100 mm Hg) 
Suture 
retention                
     (g) 
Young's 
Modulus 
(N/m
2
) 
Electrospun   
helical Scaffold 
350 ± 20 
(n=10) 
1010 ± 200 
(n=5) 
3.2 ± 0.4  
(n=20)  
162 ± 15  
(n=5) 
1.8 x 10
8  
Native 
tissue 
Saphenous vein 
 
Artery 
110-550 
 
350-700 
1600 
 
2000 
0.7-1.5 
 
4.5-6.2 
196 ± 2 
 
200 ± 120 
/ 
 
1.2 -1.3 x 10
5 
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Graphical abstract text- Parikh et al. 
 
We used an intelligent design system and the electrospinning technique to synthesise ‘small’ 
diameter nanofibrous helical scaffolds with inner ridges to allow spiral flow. Human endothelial cells 
survived well on the inner scaffold layer with better ability to withhold elevated intravascular 
pressures, than conventional scaffolds. Our novel helical scaffold can be explored as a potential 
small diameter graft to treat cardiovascular disease patients. 
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